AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Ostrow, KL DiCioccio, RA McGuire, V Whittemore, AS
Citation: Kl. Ostrow et al., A BRCA1 variant, IVS23+1G -> A, causes abnormal RNA splicing by deleting exon 23, CANC GENET, 127(2), 2001, pp. 188-190

Authors: Werness, BA Parvatiyar, P Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Wiest, J Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53, J NAT CANC, 92(13), 2000, pp. 1088-1091

Authors: Werness, BA Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation, INT J GYN P, 19(4), 2000, pp. 390-394

Authors: Allen, HJ DiCioccio, RA Hohmann, P Piver, MS Tworek, H
Citation: Hj. Allen et al., Microsatellite instability in ovarian and other pelvic carcinomas, CANC GENET, 117(2), 2000, pp. 163-166

Authors: Piver, MS Tsukada, Y Werness, BA DiCioccio, RA Whittemore, AS Ponder, BAJ
Citation: Ms. Piver et al., Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: A study by the Gilda Radner Familial Ovarian Cancer Registry, GYNECOL ONC, 78(2), 2000, pp. 166-170

Authors: Werness, BA Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations, HUMAN PATH, 31(11), 2000, pp. 1420-1424

Authors: DiCioccio, RA
Citation: Ra. Dicioccio, Literature on BRCA1 mutations not cited, AM J PATH, 156(4), 2000, pp. 1478-1478

Authors: Fetzer, S Tworek, HA Piver, MS DiCioccio, RA
Citation: S. Fetzer et al., Classification of IVS1-10T -> C as a polymorphism of BRCA1, CANC GENET, 113(1), 1999, pp. 58-64

Authors: Tworek, H Peng, RQ Fetzer, S Werness, BA Piver, MS Allen, HJ DiCioccio, RA
Citation: H. Tworek et al., Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors, CANC GENET, 112(2), 1999, pp. 105-118
Risultati: 1-9 |